相关实验视频

Updated: Jun 30, 2026

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 26, 2016

卡巴索尔的多参数排名用于抗试酶发现

Amrita Sharma¹, Carlos E Sanz-Rodriguez², Michael P Pollastri³

¹Department of Molecular and Cellular Biology, Kennesaw State University, Kennesaw, GA, United States.

Frontiers in drug discovery

|March 24, 2025

概括

开发了一个新的评分系统,Curaxin HAT效率 (CHLE) 评分,有助于确定有效治疗人类非洲试索米病 (HAT) 的方法. 这一分数优先考虑了像CBL0137这样的化合物,它在小鼠中成功治疗了HAT,而不是类似的化合物.

科学领域:

药物的发现和开发.
寄生虫学的寄生虫学
药品化学药品化学是一个

背景情况:

人类非洲三虫病 (HAT) 是一种被忽视的热带疾病,由 *Trypanosoma brucei* 引起.
目前在HAT发现中推进候选药物的标准尚未标准化.
标准的类似药物的特性并不总是预测治疗疗效.

研究的目的:

提出和验证一种多参数评分策略,用于在HAT领先发现中对候选药物进行排名.
确定关键参数与库拉辛化合物对 * T. brucei * 的疗效相关.
开发Curaxin HAT效率 (CHLE) 评分,以改善击中到的进展.

主要方法:

整合了物理化学,代谢,药理动力学,药理动力学,组织分布和三类性数据.
使用这些综合参数计算多参数CHLE得分.
在实验室和体内对HAT.的小鼠模型中的curaxin化合物 (CBL0137,CBL0174,CBL0187) 的评估.
评估库拉辛的作用机制,包括抑制蛋白质合成和转激素内细胞分裂.

主要成果:

在HAT的小鼠模型中,CBL0137证明了有效性,而结构类型的CBL0174和CBL0187则失败了.
血清显著降低了CBL0174和CBL0187.7的抗试酶功效.
CBL0137的有效性与高AUC0-6h:DTC90比率相关,阻断了转激素内细胞分裂,并抑制了蛋白质合成.
在CHLE得分中,CBL0137被成功列为最高得分的命中者,预测其优异的表现.

结论:

与传统标准相比,CHLE评分系统提供了一种更准确的方法来对HAT领先发现中的候选药物进行排名.
多参数评估对于预测针对被忽视疾病的化合物的体内疗效至关重要.
CHLE评分背后的原则可以适用于开发其他传染病的发现策略.

关键词:

毒品的作用方式毒品的作用方式击中到领先的选择选择.传染病是一种传染性疾病.疾病的小鼠模型.寄生虫寄生虫是一种寄生虫.试用松酸盐的方法

更多相关视频

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

Published on: November 5, 2021

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

相关概念视频

Anthelminthic Agents

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...

Antiprotozoal Agents

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...